Serial Number | 97507484 |
Word Mark | KERNAL |
Filing Date | Monday, July 18, 2022 |
Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
Status Date | Tuesday, October 29, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, September 3, 2024 |
Goods and Services | Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes |
Goods and Services | Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; nucleic acid sequences for scientific purposes; polypeptide encoding nucleic acids for laboratory use |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 8, 2022 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, August 8, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Kernal Biologics |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02139 |
Party Name | Kernal Biologics |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02139 |
Event Date | Event Description |
Thursday, July 21, 2022 | NEW APPLICATION ENTERED |
Monday, August 8, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, May 3, 2023 | ASSIGNED TO EXAMINER |
Wednesday, May 3, 2023 | NON-FINAL ACTION WRITTEN |
Wednesday, May 3, 2023 | NON-FINAL ACTION E-MAILED |
Wednesday, May 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, July 21, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Friday, July 21, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Wednesday, October 18, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Wednesday, October 18, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Wednesday, October 18, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Wednesday, October 18, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, October 18, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Monday, October 30, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, October 30, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, October 30, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, December 4, 2023 | FINAL REFUSAL WRITTEN |
Monday, December 4, 2023 | FINAL REFUSAL E-MAILED |
Monday, December 4, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Thursday, August 1, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, August 1, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, August 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, August 1, 2024 | EXAMINERS AMENDMENT E-MAILED |
Thursday, August 1, 2024 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, August 14, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 3, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, September 3, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, October 29, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |